by Dr. Joseph Mercola, Mercola:
STORY AT-A-GLANCE
- The World Health Organization’s International Agency for Research on Cancer estimates more than 35 million new cancer cases in 2050
- This represents a 77% increase from the estimated 20 million cancer cases that occurred in 2022
- WHO blamed the rising cancer rates on an aging population, along with tobacco, alcohol, obesity and exposure to air pollution
- WHO ignored the emergence of rapid-growing “turbo cancers” in people who have received one or more COVID-19 shots
- Many of these cancers are showing up in young people, many under age 30, with no family history of cancer; treatment protocols are available to help recover from post-jab injuries
TRUTH LIVES on at https://sgtreport.tv/
The World Health Organization’s International Agency for Research on Cancer (IARC) released a daunting prediction of the global cancer burden. It estimates more than 35 million new cancer cases in 2050 — a 77% increase from the estimated 20 million cancer cases that occurred in 2022.1
While WHO named an aging population as a key driver behind the increasing cancer burden, along with tobacco, alcohol, obesity and exposure to air pollution, what they’re ignoring is the concerning trend of turbo cancers that occur shortly after COVID-19 shots.
Cancer Cases Set to Increase Significantly by 2050
The IARC cancer burden estimates are based on the “best sources of data available in [185] countries in 2022.”2 That year, there were an estimated 20 million new cancer cases and 9.7 million deaths, with WHO reporting, “About 1 in 5 people develop cancer in their lifetime, approximately 1 in 9 men and 1 in 12 women die from the disease.”3
About two-thirds of the new cancer cases and deaths were caused by 10 types of cancer. Lung cancer was most common, followed by female breast cancer, colorectal cancer, prostate cancer and stomach cancer. When broken down by sex, breast cancer was the most commonly diagnosed — and the leading cause of cancer death — among women. For men, it was lung cancer.
Lung cancer and colorectal cancer accounted for the second and third most diagnosed types and cause of most deaths among women. However, for men, prostate and colorectal cancers were second and third most common, while liver and colorectal cancer caused the second and third most cancer deaths.4
There were also disparities revealed based on human development index (HDI), a statistical tool that assesses three dimensions of human development: a long and healthy life, access to knowledge (schooling) and a decent standard of living. According to WHO:5
“In terms of the absolute burden, high HDI countries are expected to experience the greatest absolute increase in incidence, with an additional 4.8 million new cases predicted in 2050 compared with 2022 estimates. Yet the proportional increase in incidence is most striking in low HDI countries (142% increase) and in medium HDI countries (99%). Likewise, cancer mortality in these countries is projected to almost double in 2050.”
What’s Driving Up Cancer Rates?
WHO blamed the projected cancer burden increase on a combination of age and environmental factors, stating:6
“The rapidly growing global cancer burden reflects both population ageing and growth, as well as changes to people’s exposure to risk factors, several of which are associated with socioeconomic development. Tobacco, alcohol and obesity are key factors behind the increasing incidence of cancer, with air pollution still a key driver of environmental risk factors.”
But it did not mention the emergence of rapid-growing cancers of the breast, colon, esophagus, kidney, liver, pancreas, bile duct, brain, lung and blood — including exceedingly rare types of cancer. As noted by Canadian oncologist and cancer researcher Dr. William Makis in the Highwire interview above,7 these cancers are showing up in young people, many under age 30, with no family history of cancer.
They’re showing up in pregnant women and young children. Equally odd is the fact that most are Stage 3 or 4 by the time they’re diagnosed, with symptoms arising only days or weeks before. The cancers grow and spread so rapidly, many of these patients die before treatment can even begin. Most of them are also resistant to conventional treatment.
The phenomenon has become common enough that the term “turbo cancers” was coined to describe these rapid-growing cancers in people who have received one or more COVID jabs.
Turbo Cancer Cases Reported Following COVID-19 Shots
In a case report described by board-certified internist and cardiologist Dr. Peter McCullough and colleagues, basaloid carcinoma, a type of aggressive cancer, developed in a 56-year-old man shortly after he received an mRNA COVID-19 shot.
Early symptoms, which began just four days after the jab, were similar to those caused by Bell’s palsy, and involved head pain — but soon a tumor developed on his ear and face. According to the study:8
“We place this within the context of multiple immune impairments potentially related to the mRNA injections that would be expected to potentiate more aggressive presentation and progression of cancer. The type of malignancy we describe suggests a population risk for occurrence of a large variety of relatively common basaloid phenotype cancer cells, which may have the potential for metastatic disease.
… Since facial paralysis/pain is one of the more common adverse neurological events following mRNA injection, careful inspection of cutaneous/soft tissue should be conducted to rule out malignancy.”
This is just one example. Another case report, published in Frontiers in Medicine,9 also found a “rapid progression” of angioimmunoblastic T-cell lymphoma (AITL) — a rare type of non-Hodgkin lymphoma (NHL) — following an mRNA COVID booster shot. AITL is a cancer that affects the lymph system, primarily involving T-cells, a type of white blood cell that plays a crucial role in the immune system.
“Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on neoplasms affecting this cell type,” the study notes.10
The cancer occurred in a 66-year-old man, mere days after he got his third Pfizer shot. Ironically, he got the shot to protect him during chemotherapy, and in eight days, the cancer just exploded and spread like wildfire.
